Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches

Arch Pathol Lab Med. 2010 Oct;134(10):1534-40. doi: 10.5858/2009-0581-OA.1.

Abstract

Context: The association of circulating donor-specific antibody (DSA) strength with crossmatch results is of potential interest to predict allograft outcome.

Objectives: To systematically investigate the aforementioned association and to attempt to define a cutoff value for DSA strength that can predict a positive crossmatch result.

Design: We analyzed DSA strength and crossmatch results from the 2006 to 2008 proficiency testing samples of the American Society of Histocompatibility and Immunogenetics (n = 50). We further validated our findings in candidates for potential kidney transplant (n = 19).

Results: Proficiency test samples with positive antihuman globulin T-cell crossmatch results had significantly higher DSA strength, as assessed by Luminex (Austin, Texas) mean fluorescent intensity (MFI; MFI [SD], 7860 [4770]), compared with samples with negative crossmatch results (MFI [SD], 2900 [1820]; P = .001). Similarly, higher Luminex values were observed in samples from candidates for transplant with positive antihuman globulin T-cell crossmatch results (MFI [SD], 7910 [2370] versus 2840 [1960]; P < .001). The MFI value of 6540 had 61% and 75% sensitivity and 92% and 94% specificity for predicting positive antihuman globulin T-cell crossmatches in proficiency test samples and in candidates for transplant, respectively.

Conclusions: The DSA strength correlates well with crossmatch results. An MFI of 6540 predicted a positive antihuman globulin T-cell crossmatch.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / blood
  • Antilymphocyte Serum / immunology
  • HLA Antigens / immunology*
  • Histocompatibility Testing / methods*
  • Histocompatibility Testing / standards
  • Humans
  • Immunogenetics / methods
  • Immunogenetics / standards
  • Isoantibodies / immunology
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / statistics & numerical data
  • Patient Selection
  • Predictive Value of Tests
  • Reproducibility of Results
  • T-Lymphocytes / immunology
  • Tissue Donors*
  • Transplantation Immunology / immunology
  • Transplantation, Homologous / standards
  • Treatment Outcome

Substances

  • Antibodies
  • Antilymphocyte Serum
  • HLA Antigens
  • Isoantibodies